The Business Case for Perinatal Mental Health Benefits
Written by
Phoenix Health Editorial Team
Expert health information, double-checked for accuracy and written to be helpful.
Last updated
Written by
Phoenix Health Editorial Team
Expert health information, double-checked for accuracy and written to be helpful.
Last updated
Untreated perinatal mood and anxiety disorders (PMADs) cost an estimated $14.2 billion every year for a single U.S. birth cohort, tracked from conception through the child's fifth birthday. That figure comes from Mathematica's national cost analysis, and it represents costs your organization is almost certainly absorbing right now without attributing them to their source.
Postpartum depression is the most common complication of childbirth. It affects roughly 1 in 5 birthing employees, and about 75% of affected individuals never receive treatment. The consequences do not stay in the clinical column. They surface as catastrophic claims, surgical deliveries, NICU stays, extended disability leave, and workforce exits.
For a CFO or VP of Benefits, this is not a wellness initiative. It is a claims exposure and talent retention problem with a measurable price tag and a defined intervention.
What Untreated PMADs Actually Cost
The Mathematica model puts the cost of untreated PMADs at $31,800 to $35,910 per affected mother-infant dyad over five years. That range is the number to anchor your analysis to, because it converts a national abstraction into a per-case figure your actuaries can apply against your covered population.
Roughly 60% of that cost is front-loaded to the maternal experience, with the remaining 40% attributed to child outcomes. The front-loading matters more than the split itself. The most catastrophic medical events cluster inside the gestational and immediate neonatal window, which means a prevention dollar spent today pays back inside the same policy year, not a decade later.
The clinical drivers are specific and priced. Among the PMAD population, preeclampsia runs 6.08% to 8.53%, carrying $1,285 in incremental cost per case. Cesarean delivery occurs at 39.61% versus a 31.90% baseline, and each avoided C-section is worth $11,693. Inpatient stays extend to 2.86 days versus 2.60, at $2,340 per day. Across six years, PMADs generate roughly $17,100 in excess medical cost per mother.
Preterm birth is the line item that breaks budgets. Employees with untreated PMADs are 2.4 times more likely to deliver preterm, producing an estimated 61,098 additional preterm births nationally per cohort. A single severe NICU admission can run $100,000 to $300,000 and easily breach a stop-loss threshold. One avoided preterm birth offsets years of preventive care investment for an entire covered population.
The Productivity Tax
Productivity losses are the single largest component of the Mathematica total: $4.7 billion, or 33% of the $14.2 billion. This is the cost that never appears in your medical claims data, which is precisely why it goes unmanaged.
Absenteeism is measurable and visible. Presenteeism, the reduced output of an employee who is present but impaired, is larger and harder to see. Both are dwarfed by attrition. When a new parent leaves the workforce, the replacement cost of $45,000 to $100,000 does not land in the health claims database. It lands in HR's talent budget, in a separate cost center, often attributed to voluntary turnover with no link back to an untreated clinical condition.
This split is the core reason perinatal mental health gets underfunded. The savings accrue to two different departments, so no single owner sees the full return. Any credible ROI calculation has to span both the medical claims line and the talent budget, or it understates the case by the largest single factor.
It also explains why a standard employee assistance program rarely moves these numbers. Short-session, generalist EAP models are not built for a clinical population that needs specialized, sustained perinatal care. We cover this gap in detail in our guide to where EAP falls short for perinatal populations.
HEDIS Screening Compliance in 2026
Health plan screening performance for this population is poor, and the commercial numbers are worse than Medicaid. NCQA's 2023 HEDIS data shows prenatal depression screening (PND-E) at 13.2% for Medicaid and 5.1% for commercial plans. Postpartum screening (PDS-E) came in at 8.7% for Medicaid and 4.4% for commercial. A commercial plan screening 5% of pregnant members is leaving the vast majority of preventable cases undetected.
The compliance stakes rise in 2026. NCQA is phasing out hybrid chart abstraction in favor of the Electronic Clinical Data Systems (ECDS) reporting standard, which requires structured, LOINC-coded electronic data. Organizations that have not restructured their EHR workflows to capture screening as discrete coded data face measurement gaps, financial penalties, and exclusion from value-based care networks that require ECDS-ready reporting.
Several states already attach dollars to screening. Pennsylvania offers a $5 to $10 per-member-per-month bonus. Connecticut runs a pay-for-performance program. North Carolina pays a $50 screening incentive per patient. These programs signal where commercial contracting is heading: screening rates are becoming a contracted performance metric, not a quality footnote.
Building the ROI Argument
The honest objection to investing in perinatal mental health is the attribution problem. Payers hesitate because members change carriers, and long-term savings from a healthier child may accrue to a different insurer years later. Medicaid made this worse for years by terminating coverage 60 days postpartum, ejecting vulnerable mothers at the exact point when suicide risk peaks. In Texas, 64% of postpartum residents became uninsured within three months of birth, and 88% experienced a coverage gap at some point in the first year.
That objection collapses under the front-loading data. The most catastrophic costs, preterm births, NICU admissions, surgical deliveries, and maternal psychiatric hospitalizations, occur inside the current policy year. For a self-funded employer, prevention pays back within the same 12-month contracting cycle. You are not betting on a payoff that lands with the next carrier. You are reducing claims you would otherwise pay this plan year.
For employers, the retained productivity argument is the decisive one. Avoiding a single workforce exit is worth more than a full year of perinatal benefit costs for many covered employees. Self-funded employers capture value through retained productivity even where health plan savings are harder to isolate.
The aggregate evidence supports the spend. A 19-cohort analysis of more than 42,000 participants found a pooled 2.3x ROI on enhanced behavioral health services, equal to $159 per-member-per-month in net savings, rising to 4.0x with organizational efficiencies. McKinsey estimates $2.70 in economic benefit per $1 invested in maternal and children's health. RAND puts the long-term return on child and youth mental health investment at $1.80 to $17.07 per dollar.
What Best-In-Class Coverage Looks Like
Your peers are already running these programs, and the published outcomes establish the benchmark. Treat the vendor data below as the standard your benefit will be measured against.
Maven Clinic reports 27% lower NICU admission rates, 20% lower odds of C-section, a 94% return-to-work rate, and roughly $5,000 in savings per member, with 96% of members reporting greater loyalty to their employer. Ovia Health reports a 4:1 ROI, a 54% reduction in preterm deliveries worth about $95,000 in cost avoidance per prevented preterm birth, a 34% reduction in C-sections, and 88% retention at one year post-birth. Cleo reports $2,701 in savings per family and a 400% increase in mental health benefit utilization, while finding that 60% of caregivers screen positive for depression or anxiety on the PHQ-4.
Set those return-to-work and retention figures against the national baseline: only 57% of new parents successfully return to work. A 94% return-to-work rate against a 57% baseline is the productivity argument made concrete.
The common thread across the strongest performers is comprehensive, specialized clinical care delivered early, not a generalist benefit bolted onto an existing plan. For the practical mechanics of evaluating and structuring perinatal benefits, our guide for benefits brokers covers the full vendor evaluation framework.
The Clinical Delivery Layer
The outcomes above depend on the quality of the care actually delivered. Phoenix Health provides the specialized clinical layer that produces them. Most Phoenix Health therapists hold PMH-C certification, the perinatal mental health credential from Postpartum Support International, so employees receive care from clinicians trained specifically for this population rather than generalists.
Care is delivered via telehealth, removing the access barriers that keep new parents from treatment. Phoenix Health is in-network with major insurers and turns around referrals within one business day.
Ready to add specialized perinatal mental health to your benefits package? Talk to our team about structuring coverage for your organization.
Frequently Asked Questions
Untreated perinatal mood and anxiety disorders cost an estimated $14.2 billion annually for a single U.S. birth cohort, which works out to $31,800 to $35,910 per affected mother-infant dyad over five years, according to Mathematica's national modeling. For employers, the largest single component is productivity loss at $4.7 billion, or 33% of the total, driven by absenteeism, presenteeism, and workforce attrition. Across six years, PMADs generate roughly $17,100 in excess medical cost per affected mother. Medical drivers include higher rates of cesarean delivery ($11,693 per avoided C-section), extended inpatient stays, preeclampsia, and a 2.4 times higher likelihood of preterm birth. A single severe NICU admission can run $100,000 to $300,000 and breach stop-loss thresholds. Much of this cost is invisible because productivity and attrition losses land in the talent budget rather than the medical claims database.
PND-E (prenatal depression screening and follow-up) and PDS-E (postpartum depression screening and follow-up) are NCQA HEDIS measures that increasingly function as contracted performance metrics. As of 2023 reporting, commercial plan performance was low: 5.1% for prenatal screening and 4.4% for postpartum screening. Starting in 2026, NCQA is phasing out hybrid chart abstraction in favor of the ECDS reporting standard, which requires structured, LOINC-coded electronic data. Plans that have not restructured EHR workflows face measurement gaps, financial penalties, and exclusion from value-based care networks. Several states already attach financial incentives to screening, including Pennsylvania's $5 to $10 per-member-per-month bonus, Connecticut's pay-for-performance program, and North Carolina's $50 screening incentive. For payers and plan sponsors, screening rates are shifting from a quality footnote to a contracted requirement.
A 19-cohort analysis of more than 42,000 participants published in the Journal of Health Economics and Outcomes Research found a pooled 2.3x ROI on enhanced behavioral health services, equal to $159 per-member-per-month in net savings, rising to 4.0x with organizational efficiencies. McKinsey estimates $2.70 in economic benefit per $1 invested in maternal and children's health. For self-funded employers specifically, the return is strong because the most catastrophic costs occur within the current 12-month policy year, so prevention pays back inside the same contracting cycle rather than accruing to a future carrier. The retained productivity argument adds to this: avoiding a single workforce exit, at a replacement cost of $45,000 to $100,000, can exceed a full year of perinatal benefit costs for many covered employees.
Specialized platforms reduce high-cost claims by screening early, identifying at-risk members during pregnancy, and delivering sustained clinical care before complications escalate. The published outcomes are specific. Maven Clinic reports 27% lower NICU admission rates and 20% lower odds of cesarean delivery. Ovia Health reports a 54% reduction in preterm deliveries, worth roughly $95,000 in cost avoidance per prevented preterm birth, plus a 34% reduction in C-sections. These reductions matter financially because employees with untreated PMADs are 2.4 times more likely to deliver preterm, and a single severe NICU admission can run $100,000 to $300,000, often breaching stop-loss thresholds. By concentrating intervention in the gestational window where the most expensive events occur, these platforms convert preventive spend into avoided catastrophic claims within the same policy year.
Brokers should prioritize vendors that demonstrate measurable clinical outcomes rather than engagement metrics alone. Look for published data on NICU admission rates, cesarean and preterm birth reduction, return-to-work rates, and per-member savings, and compare them against national baselines (for example, a 57% return-to-work baseline). Confirm the clinical model uses perinatal-specialized providers, such as clinicians holding PMH-C certification from Postpartum Support International, rather than generalist counselors. Verify in-network status with major insurers, telehealth access, and referral turnaround times. Assess HEDIS readiness, including the ability to capture PND-E and PDS-E screening as structured, LOINC-coded ECDS data ahead of the 2026 transition. Finally, confirm the vendor can report ROI across both medical claims and productivity, since the largest cost component sits in the talent budget rather than the medical line.
Ready to partner?
Add perinatal mental health to your benefits
Available nationwide. Covers 90% of the U.S. Flexible, discounted access for employees and their families.
Perinatal benefits research, ROI data, and what leading employers are getting right, delivered to your inbox.